Lee Danner & Bass Inc Abbott Laboratories Transaction History
Lee Danner & Bass Inc
- $1.17 Billion
- Q4 2023
A detailed history of Lee Danner & Bass Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Lee Danner & Bass Inc holds 35,726 shares of ABT stock, worth $3.68 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
35,726
Previous 36,066
0.94%
Holding current value
$3.68 Million
Previous $3.49 Million
12.57%
% of portfolio
0.34%
Previous 0.32%
Shares
27 transactions
Others Institutions Holding ABT
# of Institutions
3,132Shares Held
1.29BCall Options Held
8.43MPut Options Held
8.71M-
Vanguard Group Inc Valley Forge, PA165MShares$17 Billion0.38% of portfolio
-
Black Rock Inc. New York, NY133MShares$13.7 Billion0.36% of portfolio
-
Capital Research Global Investors Los Angeles, CA84MShares$8.65 Billion2.23% of portfolio
-
State Street Corp Boston, MA74.7MShares$7.7 Billion0.39% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$7.23 Billion1.65% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $180B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...